These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 8345495
21. Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension. Nussberger J, Gradman AH, Schmieder RE, Lins RL, Chiang Y, Prescott MF. Int J Clin Pract; 2007 Sep; 61(9):1461-8. PubMed ID: 17590217 [Abstract] [Full Text] [Related]
22. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension. Planz G, Beckenbauer U, Bundschu HD. Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755 [Abstract] [Full Text] [Related]
23. Arterial stiffness is related to augmented seasonal variation of blood pressure in hypertensive patients. Youn JC, Rim SJ, Park S, Ko YG, Kang SM, Choi D, Ha JW, Jang Y, Chung N. Blood Press; 2007 Oct; 16(6):375-80. PubMed ID: 18058455 [Abstract] [Full Text] [Related]
24. Serum testosterone levels and arterial blood pressure in the elderly. Fogari R, Preti P, Zoppi A, Fogari E, Rinaldi A, Corradi L, Mugellini A. Hypertens Res; 2005 Aug; 28(8):625-30. PubMed ID: 16392765 [Abstract] [Full Text] [Related]
25. Effects of alcohol withdrawal on blood pressure in hypertensive heavy drinkers. Soardo G, Donnini D, Varutti R, Milocco C, Basan L, Esposito W, Casaccio D, Isola M, Soldano F, Sechi LA. J Hypertens; 2006 Aug; 24(8):1493-8. PubMed ID: 16877950 [Abstract] [Full Text] [Related]
26. Dissociation of augmented physiological, hormonal and cognitive responses to hypoglycaemia with sustained caffeine use. Watson JM, Sherwin RS, Deary IJ, Scott L, Kerr D. Clin Sci (Lond); 2003 Apr; 104(4):447-54. PubMed ID: 12653691 [Abstract] [Full Text] [Related]
27. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study. Ishikawa J, Kario K, Eguchi K, Morinari M, Hoshide S, Ishikawa S, Shimada K, J-MORE Group. Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523 [Abstract] [Full Text] [Related]
28. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial. Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR. J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225 [Abstract] [Full Text] [Related]
29. The Hypertension Optimal Treatment study and the importance of lowering blood pressure. Hansson L. J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838 [Abstract] [Full Text] [Related]
30. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study. Punzi HA, Punzi CF. J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114 [Abstract] [Full Text] [Related]
31. [The effect of reduced sodium intake on blood pressure, body weight, renin, aldosterone, catecholamines, cholesterol and triglycerides. A meta-analysis]. Graudal NA, Galløe AM, Garred P. Ugeskr Laeger; 1999 Apr 26; 161(17):2526-30. PubMed ID: 10327874 [Abstract] [Full Text] [Related]
32. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension. Ding YA, Chang SM, Chou TC. J Hum Hypertens; 1995 Aug 26; 9(8):637-41. PubMed ID: 8523379 [Abstract] [Full Text] [Related]
33. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol. Radauceanu A, Boivin JM, Bernaud C, Fay R, Zannad F, CIC General Practitioners Investigators' Group. Fundam Clin Pharmacol; 2004 Aug 26; 18(4):483-91. PubMed ID: 15312156 [Abstract] [Full Text] [Related]
34. Inhibition of plasma endothelin-1 concentration by captopril in patients with essential hypertension. Uemasu J, Munemura C, Fujihara M, Kawasaki H. Clin Nephrol; 1994 Mar 26; 41(3):150-2. PubMed ID: 8187357 [Abstract] [Full Text] [Related]
35. Lercanidipine vs lacidipine in isolated systolic hypertension. Millar-Craig M, Shaffu B, Greenough A, Mitchell L, McDonald C. J Hum Hypertens; 2003 Nov 26; 17(11):799-806. PubMed ID: 14578921 [Abstract] [Full Text] [Related]
36. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M. Nutr Metab Cardiovasc Dis; 2006 Mar 26; 16(2):137-47. PubMed ID: 16487914 [Abstract] [Full Text] [Related]
37. The effect of an herbal supplement containing black tea and caffeine on metabolic parameters in humans. Roberts AT, de Jonge-Levitan L, Parker CC, Greenway F. Altern Med Rev; 2005 Dec 26; 10(4):321-5. PubMed ID: 16366740 [Abstract] [Full Text] [Related]
38. The effect of caffeine on the cardiovascular responses to head-up tilt. Berry NM, Rickards CA, Newman DG. Aviat Space Environ Med; 2003 Jul 26; 74(7):725-30. PubMed ID: 12862326 [Abstract] [Full Text] [Related]
39. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines. Lechi A, Picotti GB, Covi G, Pomari S, Pedrolli E, Cesura AM, Danti G, Mattioli M. Arzneimittelforschung; 1981 Jul 26; 31(3):524-6. PubMed ID: 7013770 [Abstract] [Full Text] [Related]